The DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Orexins and fear: implications for the treatment of anxiety disorders
Abstract
An understanding of the neurobiological mechanisms involved in the regulation of fear is essential for the development of new treatments for anxiety disorders, such as phobias, panic, and post-traumatic stress disorders (PTSD). Orexins, also known as hypocretins, are neuropeptides located exclusively in hypothalamic neurons that have extensive projections throughout the central nervous system. Although this system was initially believed to be primarily involved in the regulation of feeding behavior, recent studies have shown that orexins also modulate neural circuits implicated in the expression and extinction of fear memories. Here, we discuss recent findings involving orexins in anxiety disorders and current clinical trials using orexin ligands that could be applied to identify new therapies for diseases characterized by pathological fear.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The orexin receptor 1 and/or orexin receptor 2 receptor are expressed in several brain areas that are engaged during anxiety and fear processing including the hippocampus, amygdala and mPFC (Flores, Saravia, Maldonado, & Berrendero, 2015;Marcus et al., 2001).”
From Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders (2019) · cites this paper as Flores, Saravia, Maldonado, & Berrendero, 2015
In the citing paper
“Furthermore, activation of the orexin system has been shown to be involved in the expression and consolidation of fear while it counteracts fear extinction (Flores et al., 2015).”
From Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders (2019) · cites this paper as Flores et al., 2015
Citations
Cites
LeDoux, J. E. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.155 · Cited by 8,444
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095
Kessler, R. C., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Wittchen, H. (2012) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1359 · Cited by 2,947
Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P. J., Nishino, S., & Mignot, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81965-0 · Cited by 2,613
Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R., et al. (2000) · Nature Medicine · doi:10.1038/79690 · Cited by 2,118
Cited by
Sorted by citations
Inhibition in the amygdala anxiety circuitry
Babaev, O., Chatain, C. P., & Krueger‐Burg, D. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0063-8 · Cited by 334
Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour
Bonnavion, P., Mickelsen, L. E., Fujita, A., de Lecea, L., & Jackson, A. C. (2016) · The Journal of Physiology · doi:10.1113/jp271946 · Cited by 271
Sartori, S. B., & Singewald, N. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107402 · Cited by 236
The Brainstem in Emotion: A Review
Venkatraman, A., Edlow, B. L., & Immordino‐Yang, M. H. (2017) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2017.00015 · Cited by 238
The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders
Sanacora, G., Yan, Z., & Popoli, M. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00540-x · Cited by 197
Zhang, Y., Ren, R., Sanford, L. D., Yang, L., Zhou, J., Zhang, J., Wing, Y. K., Shi, J., Lü, L., & Tang, X. (2019) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2019.08.004 · Cited by 145
Grafe, L. A., & Bhatnagar, S. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.06.003 · Cited by 136
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Han, Y., Yuan, K., Zheng, Y., & Lü, L. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00447-9 · Cited by 122
Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders
James, M. H., Campbell, E. J., & Dayas, C. V. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_56 · Cited by 112
Hypocretins (orexins): The ultimate translational neuropeptides
Jacobson, L. H., Hoyer, D., & de Lecea, L. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13406 · Cited by 113
The hypothalamus as a primary coordinator of memory updating
Burdakov, D., & Peleg‐Raibstein, D. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112988 · Cited by 80
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions
Fagan, H. A., & Baldwin, D. S. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2211767 · Cited by 82
Pałasz, A., Janas-Kozik, M. H., Borrow, A. P., Arias-Carrión, Ó., & Worthington, J. J. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.12.006 · Cited by 58
Salvadore, G., Bonaventure, P., Shekhar, A., Johnson, P. L., Lord, B., Shireman, B. T., Lebold, T. P., Nepomuceno, D. H., Dugovic, C., Brooks, S., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00937-9 · Cited by 50
Ten-Blanco, M., Flores, Á., Cristino, L., Pereda-Pérez, I., & Berrendero, F. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101066 · Cited by 48
Self-citationWilson, M. A., Liberzon, I., Lindsey, M. L., Lokshina, Y., Risbrough, V. B., Sah, R., Wood, S. K., Williamson, J. B., & Spinale, F. G. (2019) · Stress · doi:10.1080/10253890.2019.1621283 · Cited by 48
Bonaventure, P., Dugovic, C., Shireman, B. T., Préville, C., Yun, S., Lord, B., Nepomuceno, D. H., Wennerholm, M. L., Lovenberg, T. W., Carruthers, N., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00357 · Cited by 46
Hou, L., Yang, P., Jiang, F., Liu, Q. F., Wang, X., & Kang, L. (2017) · eLife · doi:10.7554/elife.22526 · Cited by 42
Jászberényi, M., Thurzó, B., Bagosi, Z., Vécsei, L., & Tanaka, M. (2024) · Biomedicines · doi:10.3390/biomedicines12020448 · Cited by 42
Cohen, S., Matar, M. A., Vainer, E., Zohar, J., Kaplan, Z., & Cohen, H. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0698-9 · Cited by 42
Prajapati, S. K., & Krishnamurthy, S. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113015 · Cited by 42
Jaz, E. K., Moghimi, A., Fereidoni, M., Asadi, S., Shamsizadeh, A., & Roohbakhsh, A. (2017) · Fundamental & Clinical Pharmacology · doi:10.1111/fcp.12249 · Cited by 41
Salehabadi, S., Abrari, K., Salmani, M. E., Nasiri, M., & Lashkarbolouki, T. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112455 · Cited by 40
Flores, Á., Herry, C., Maldonado, R. J., & Berrendero, F. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx029 · Cited by 39
Self-citationThe anxiolytic-like effects of ginsenoside Rg3 on chronic unpredictable stress in rats
Xu, J., Chen, L.-F., Su, J., Liu, Z., Chen, J., Lin, Q.-F., Mao, W.-D., & Shen, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-26146-5 · Cited by 36
Orexin A in adolescents with anxiety disorders
Akça, Ö. F., Uzun, N., & Kılınç, İ. (2020) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2019.1711425 · Cited by 35
Sharko, A. C., Fadel, J. R., Kaigler, K. F., & Wilson, M. A. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.10.008 · Cited by 38
Yaeger, J. D. W., Krupp, K. T., Jacobs, B., Onserio, B. O., Meyerink, B. L., Cain, J. T., Ronan, P. J., Renner, K. J., Dileone, R., & Summers, C. H. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.12.019 · Cited by 36
Eacret, D., Grafe, L. A., Dobkin, J., Gotter, A. L., Renger, J. J., Winrow, C. J., & Bhatnagar, S. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.05.032 · Cited by 31
Souffi, S., Nodal, F. R., Bajo, V. M., & Edeline, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.690223 · Cited by 29
Noritake, A., Ninomiya, T., & Isoda, M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.018 · Cited by 29
Kukkonen, J. P., Jacobson, L. H., Hoyer, D., Rinne, M. K., & Borgland, S. L. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.000953 · Cited by 33
The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders
Moorman, D. E. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4871-2 · Cited by 31
James, M. H., Fragale, J. E. C., O’Connor, S. L., Zimmer, B. A., & Aston‐Jones, G. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108359 · Cited by 30
Berteotti, C., Liguori, C., & Pace, M. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.15077 · Cited by 30
Fagan, H. A., Jones, E., & Baldwin, D. S. (2022) · CNS Drugs · doi:10.1007/s40263-022-00974-6 · Cited by 31
Acute sleep interventions as an avenue for treatment of trauma-associated disorders
Swift, K. M., Thomas, C. L., Balkin, T. J., Lowery‐Gionta, E. G., & Matson, L. M. (2022) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10074 · Cited by 30
Brodnik, Z. D., Alonso, I. P., Xu, W., Zhang, Y., Kortagere, S., & España, R. A. (2018) · Brain Research · doi:10.1016/j.brainres.2018.07.027 · Cited by 27
Bonifazi, A., Bello, F. D., Giorgioni, G., Piergentili, A., Saab, E., Botticelli, L., Cifani, C., Bonaventura, E. M. D., Bonaventura, M. V. M. D., & Quaglia, W. (2023) · Medicinal Research Reviews · doi:10.1002/med.21959 · Cited by 28
Role of the orexin (hypocretin) system in contextual fear conditioning in rats
Wang, H., Li, S., & Kirouac, G. J. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.052 · Cited by 29
Fasting enhances extinction retention and prevents the return of fear in humans
Shi, L., Deng, J.-H., Chen, S.-J., Que, J.-Y., Sun, Y.-K., Wang, Z., Guo, X., Han, Y., Zhou, Y.-X., Zhang, X., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0260-1 · Cited by 26
On making (and turning adaptive to) maladaptive aversive memories in laboratory rodents
Gazarini, L., Stern, C. A. J., & Bertoglio, L. J. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105101 · Cited by 27
Ikeno, T., & Yan, L. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.002 · Cited by 26
Orexin/hypocretin receptor gene (HCRTR1) variation is associated with aggressive behaviour
Harro, J., Laas, K., Eensoo, D., Kurrikoff, T., Sakala, K., Vaht, M., Parik, J., Mäestu, J., & Veidebaum, T. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.009 · Cited by 26
Ten-Blanco, M., Flores, Á., Pereda-Pérez, I., Piscitelli, F., Izquierdo-Luengo, C., Cristino, L., Romero, J., Hillard, C. J., Maldonado, R. J., Marzo, V. D., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112925 · Cited by 29
Self-citationAsadi, S., Roohbakhsh, A., Shamsizadeh, A., Fereidoni, M., Kordijaz, E., & Moghimi, A. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0445-9 · Cited by 23
Han, D., Shi, Y., & Han, F. (2021) · The Journal of Comparative Neurology · doi:10.1002/cne.25231 · Cited by 23
de Sevilla, M. E. F., Pignatelli, J., Zegarra-Valdivia, J. A., Méndez, P., Núñez, Á., & Torres‐Alemán, I. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01442-9 · Cited by 23
Lopes, L. T., Fournier, S., Henry, M. S., Bretzner, F., & Kinkead, R. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01076-x · Cited by 24
Imperatore, R., Palomba, L., Morello, G., Spiezio, A. D., Piscitelli, F., Marzo, V. D., & Cristino, L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.009 · Cited by 24
Faesel, N., Kolodziejczyk, M. H., Koch, M., & Fendt, M. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147199 · Cited by 23
Representation of distinct reward variables for self and other in primate lateral hypothalamus
Noritake, A., Ninomiya, T., & Isoda, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917156117 · Cited by 22
Clark, J. W., Daykin, H. J., Metha, J. A., Allocca, G., Hoyer, D., Drummond, S. P. A., & Jacobson, L. H. (2021) · SLEEP · doi:10.1093/sleep/zsab068 · Cited by 20
Aversive emotion rapidly activates orexin neurons and increases heart rate in freely moving mice
Yamashita, A., Moriya, S., Nishi, R., Kaminosono, J., Yamanaka, A., & Kuwaki, T. (2021) · Molecular Brain · doi:10.1186/s13041-021-00818-2 · Cited by 19
Role of medial hypothalamic orexin system in panic, phobia and hypertension
de Abreu, A. R. R., Molosh, A. I., Johnson, P. L., & Shekhar, A. (2018) · Brain Research · doi:10.1016/j.brainres.2018.09.010 · Cited by 20
Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol
Anderson, R. I., Moorman, D. E., & Becker, H. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_100 · Cited by 18
Hypocretinergic system in the medial preoptic area promotes maternal behavior in lactating rats
Rivas, M., Torterolo, P., Ferreira, A., & Benedetto, L. (2016) · Peptides · doi:10.1016/j.peptides.2016.04.002 · Cited by 17
Li, G., Zhang, K., Wang, L., Cao, C., Fang, R., Liu, P., Luo, S., & Liberzon, I. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.09.042 · Cited by 17
Zhang, Y., Ren, R., Yang, L., Zhou, J., Sanford, L. D., & Tang, X. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.019 · Cited by 17
Combination therapy with neuropeptides for the treatment of anxiety disorder
Gupta, P. R., & Prabhavalkar, K. S. (2021) · Neuropeptides · doi:10.1016/j.npep.2021.102127 · Cited by 17
Orexinergic pathway as a potential therapeutic candidate for the modulation of glucose homeostasis
Hakizimana, J. C., Izabayo, P., Izukwizabigenza, Z., & Alagbonsi, A. I. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1659753 · Cited by 16
Mirbolouk, B., Rohampour, K., Rostampour, M., Jafari, A., & Khakpour-Taleghani, B. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114123 · Cited by 14
Drug treatment strategies for insomnia in patients with post-traumatic stress disorder
Akinnusi, M. E., & Solh, A. A. E. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1574745 · Cited by 15
Messore, F., Therpurakal, R. N., Dufour, J.-P., Hoerder‐Suabedissen, A., Guidi, L., Korrell, K., Mueller, M., Abuelem, M., Lak, A., Bannerman, D. M., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03350-2 · Cited by 17
Nicholson, J. R., & Sommer, B. (2018) · Brain and Neuroscience Advances · doi:10.1177/2398212818804030 · Cited by 14
CO2 reactivity as a biomarker of exposure-based therapy non-response: study protocol
Smits, J. A. J., Monfils, M., Otto, M. W., Telch, M. J., Shumake, J., Feinstein, J. S., Khalsa, S. S., Cobb, A. R., Parsons, E. M., Long, L. J., et al. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04478-x · Cited by 12
Tissen, I. Y., Yakushina, N. D., Aa, L., Геннадиевна, П. А., Бычков, Э. Р., Tsykunov, S. G., & Shabanov, P. D. (2018) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf16134-42 · Cited by 12
Durairaja, A., Steinecke, C.-S., & Fendt, M. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113791 · Cited by 12
Orexin A Differentially Influences the Extinction Retention of Recent and Remote Fear Memory
Shi, L., Chen, W., Deng, J., Chen, S., Han, Y., Khan, M. Z., Liu, J., Que, J., Bao, Y., Lü, L., et al. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00295 · Cited by 12
Ma, C., Zhou, N., Ma, K., Niu, J., Mi, T., He, Z., Wen, Y., Liu, C., He, Z., & Niu, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1122803 · Cited by 10
Orexin receptors: possible therapeutic targets for psychiatric disorders
Chaki, S. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06767-1 · Cited by 10
Núñez-Ríos, D. L., Martínez‐Magaña, J. J., Nagamatsu, S. T., Krystal, J. H., Martínez, K., Giusti‐Rodríguez, P., & Montalvo‐Ortiz, J. L. (2023) · Complex Psychiatry · doi:10.1159/000529536 · Cited by 9
Orexin deficiency affects sensorimotor gating and its amphetamine-induced impairment
Demidova, A., Kahl, E., & Fendt, M. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110517 · Cited by 9
Lo, Y., Yi, P.-L., Hsiao, Y., & Chang, F. (2021) · SLEEP · doi:10.1093/sleep/zsab301 · Cited by 7
Pulver, A., Kiive, E., Kanarik, M., & Harro, J. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147013 · Cited by 9
Preclinical behavioral and pharmacological treatments for enhancing fear extinction in adolescence
Wall, E. K., Virakorn, E. A., Baker, K., Cohen, E. M., & Richardson, R. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106090 · Cited by 6
Hypothalamic orexins as possible therapeutic agents in threat and spatial memory disorders
Mazur, F., & Całka, J. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1228056 · Cited by 6
Effects of inhibiting the orexin system on nicotine reward memory and fear memory
Cui, P., Wu, D., Dong, J., Chen, Y. F., Feng, J., Liu, X., Chen, Z., Ge, J., & Liu, J. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110523 · Cited by 5
The Orexin System in Addiction: Neuromodulatory Interactions and Therapeutic Potential
Capó, T., Lillo, J., Rebassa, J. B., Badia, P., Raïch, I., Cubeles-Juberias, E., Reyes‐Resina, I., & Navarro, G. (2025) · Brain Sciences · doi:10.3390/brainsci15101105 · Cited by 6
Overexpression of ORX or MCH Protects Neurological Function Against Ischemic Stroke
Wu, G., Zhang, X., Li, S., Zhou, D., Bai, J., Wang, H., & Shu, Q. (2022) · Neurotoxicity Research · doi:10.1007/s12640-021-00457-4 · Cited by 5
Cristino, L., Imperatore, R., Palomba, L., & Marzo, V. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_1 · Cited by 5
Li, H., Li, X., Luo, W., & Zhu, X. (2019) · Neuroreport · doi:10.1097/wnr.0000000000001198 · Cited by 5
Faesel, N., Koch, M., & Fendt, M. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.114069 · Cited by 5
Christensen, J., Vlassopoulos, E., Barlow, C. K., Schittenhelm, R. B., Li, C. N., Sgro, M., Warren, S., Semple, B. D., Yamakawa, G. R., Shultz, S. R., et al. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114969 · Cited by 4
Orexin mechanisms in the prelimbic cortex modulate the expression of contextual conditioned fear
Oliveira, G. V. M., Hernandes, P. M., dos Santos, F. H., Soares, V. P. M. N., Falconi‐Sobrinho, L. L., Coimbra, N. C., Wotjak, C. T., & Almada, R. C. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06701-x · Cited by 3
Empathy and prosocial behavior powered by orexin-driven theta oscillations
Kim, J. G., Cron, G. O., Kim, M., Hossain, A., & Lee, J. H. (2026) · Science · doi:10.1126/science.aea7140 · Cited by 3
Fournier, S., Plamondon, J., Richard, D., & Kinkead, R. (2025) · Experimental Physiology · doi:10.1113/ep092431 · Cited by 3
Zharova, N. V., Osadchiy, A. S., Lobanova, A., Isakova, T. A., Zharov, N. A., Zharikov, Y. O., Pontes‐Silva, A., & Zharikova, T. S. (2025) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-024-00291-w · Cited by 16
Neurobiología del trastorno de estrés postraumático
Zegarra-Valdivia, J. A., & Vilca, B. N. C. (2019) · Revista de Fomento Social · doi:10.24875/rmn.m19000023 · Cited by 7
Sleep disturbances in traumatic exposure and post-traumatic stress disorder
El-Solh, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822963-7.00075-x · Cited by 3
Sex and Orexins: Uncovering a Mechanism Underlying Sex Differences in Stress Susceptibility
Holmes, A. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.02.005 · Cited by 2
Lee, T.-Y., Yi, P.-L., & Chang, F. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1196994 · Cited by 2
Kozłowska, A., Ma, W.-J., Shyu, B., & Huang, A. C. W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041414 · Cited by 2
Ten-Blanco, M., Ponce-Renilla, M., Pereda-Pérez, I., Izquierdo-Luengo, C., Bressa, C., Zafra, O., Tolón, R. M., & Berrendero, F. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03400-9 · Cited by 1
Self-citationOliveira, G. V. M., Suzuki, G. M. F., Soriano, R. F., Alves, L. D. C., de Carvalho, M. L. C., Hernandes, P. M., Wotjak, C. T., Coimbra, N. C., & Almada, R. C. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.116010 · Cited by 1
Phoenixin and nesfatin-1 – novel neuropeptides in anxiety disorders
Pałasz, A., Mordecka‐Chamera, K., Rojczyk, E., Siwiec, A., Zakrocka, M., Private Psychotherapy Practice “Relation, ”. S., & Janas-Kozik, M. H. (2020) · Psychiatria i Psychologia Kliniczna · doi:10.15557/pipk.2020.0005 · Cited by 1
Insulin-Like Growth Factor I Modulates Vulnerability to Stress Through Orexin NeuronsPreprint
de Sevilla, M. F., Pignatelli, J., Méndez, P., Zegarra-Valdivia, J. A., & Alemán, I. T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.10.941377 · Cited by 1
The Hypocretin/Orexin System and Fear Learning
Flores, Á., & Berrendero, F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813751-2.00008-5
Self-citationFlores, Á. (2017) · doi:10.26226/morressier.5971be86d462b80290b527a4
Self-citationXinxin, T., Shi, Y., Xiong, H., Sun, Y., Shi, M., Zhou, G., Dong, J., & Ren, J. (2026) · Sleep Medicine · doi:10.1016/j.sleep.2026.109057
Metadata
- Authors
- Flores, Á., Saravia, R., Maldonado, R., & Berrendero, F.
- Affiliations
- Universitat Pompeu Fabra (ES)
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 38
- Issue
- 9
- Pages
- 550-559
- ISSN
- 0166-2236 (ISSN-L)
- OpenAlex
- W1696117693
- Cited by
- 102
- References
- 101
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 4 · 2023: 8 · 2022: 12 · 2021: 9 · 2020: 14 · 2019: 10 · 2018: 15 · 2017: 9 · 2016: 6
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Neurosciences (publishedVersion)
- PubMed (publishedVersion)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- orexin, fear regulation, anxiety disorders, fear extinction, phobia, panic disorder, post-traumatic stress disorder, hypothalamus
- MeSH terms
- Orexins, Animals, Anxiety Disorders, Brain, Fear, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review